GLOBAL HEPARIN MARKET BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2022

Nov 2017 120

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.

Scope of the Report:

This report focuses on the Heparin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  • Hepalink
  • Changshan Pharm
  • Qianhong Bio-pharma
  • Opocrin
  • Pfizer
  • Aspen Oss
  • King-friend Biochemical Pharmaceutical
  • Bioibérica
  • Dongcheng Biochemicals
  • Jiulong Biochemicals
  • Tiandong
  • Xinbai
  • Yino Pharma Limited
  • Deebio

Market Segment by Regions, regional analysis covers

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

  • Heparin Sodium
  • Heparin Calcium
  • Other

Market Segment by Applications, can be divided into

  • UFH
  • LMWH

There are 15 Chapters to deeply display the global Heparin market.

Chapter 1, to describe Heparin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Heparin, with sales, revenue, and price of Heparin, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Heparin, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Heparin market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Heparin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Dec 17)

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast m...

(Dec 17)

Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezin...

(Dec 17)

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agent...

(Dec 17)

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Dis...

(Dec 17)

Fibrinogen is a protein in the blood plasma that is essential for the coagulation of blood and is converted to fibrin by the action of throm...

(Dec 17)

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intes...

GLOBAL HEPARIN MARKET BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2022


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*